SCD: A Protein as A Potential Drug Target Or Biomarker (G6319)

Target Name: SCD

NCBI ID: G6319

Content of Review Report on SCD Target / Biomarker

SCD

SCD: A Protein as A Potential Drug Target Or Biomarker

SCD (Predicted Protein of HQ0998) is a protein that has been identified as a potential drug target or biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. SCD is a key protein that is expressed in many different tissues and cells in the body, including the brain, pancreas, and gastrointestinal tract.

SCD is involved in a number of different cellular processes that are important for maintaining tissue health and function. For example, SCD is involved in the regulation of cell signaling pathways, which are critical for the development and maintenance of tissues and organs. SCD is also involved in the regulation of cell division and the maintenance of cellular homeostasis.

In addition to its role in cellular processes, SCD is also thought to play a key role in the development and progression of certain diseases. For example, SCD has been implicated in the development and progression of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. SCD is also thought to be involved in the development and progression of certain autoimmune disorders, such as rheumatoid arthritis and multiple sclerosis.

Despite its involvement in a number of important cellular processes, the precise function of SCD is not well understood. Currently, there are limited studies that have been conducted to determine the role of SCD in disease. However, research into SCD and its potential as a drug target or biomarker is an exciting area of study, with potential implications for the treatment of a wide range of diseases.

In conclusion, SCD is a protein that has been identified as a potential drug target or biomarker for a number of different diseases. Further research is needed to fully understand its role in cellular processes and its potential as a therapeutic target. If SCD is found to be involved in the development and progression of certain diseases, it may have important implications for the treatment of these diseases and for improving overall health and wellbeing.

Protein Name: Stearoyl-CoA Desaturase

Functions: Stearoyl-CoA desaturase that utilizes O(2) and electrons from reduced cytochrome b5 to introduce the first double bond into saturated fatty acyl-CoA substrates (PubMed:15907797, PubMed:18765284). Catalyzes the insertion of a cis double bond at the delta-9 position into fatty acyl-CoA substrates including palmitoyl-CoA and stearoyl-CoA (PubMed:15907797, PubMed:18765284). Gives rise to a mixture of 16:1 and 18:1 unsaturated fatty acids (PubMed:15610069). Plays an important role in lipid biosynthesis. Plays an important role in regulating the expression of genes that are involved in lipogenesis and in regulating mitochondrial fatty acid oxidation (By similarity). Plays an important role in body energy homeostasis (By similarity). Contributes to the biosynthesis of membrane phospholipids, cholesterol esters and triglycerides (By similarity)

The "SCD Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SCD comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets